Both in Pharmaceuticals
Rani Therapeutics Holdings vs Corbus Pharmaceuticals Holdings
Over the past year RANI returned −75.9% and CRBP returned −68.3%; their daily moves had a correlation of 0.30.
RANI −75.9% CRBP −68.3%Growth of $1, one year, split-adjusted
| Metric | RANI | CRBP |
|---|---|---|
| Price | $0.5728 | $3.57 |
| Market cap | $66.1M | $69.0M |
| Today | +3.06% | −7.75% |
| 1 month | −30.9% | −38.2% |
| 6 months | −40.3% | −67.3% |
| Year to date | −57.6% | −56.1% |
| 1 year | −73.4% | −71.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −432.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 13.6× | — |
| Net cash | $53.4M | $117.9M |
| Dividend yield | — | — |
| Volatility (60d) | 63.6% | 72.2% |
| Short % of float | 10.4% | 14.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).